Clinical Trial Update: Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine [Phase 3]

View source ↗

Summary

Phase 3 long-term safety study of rimegepant in pediatric patients for acute treatment of migraine, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Rimegepant (rimegepant)

Snippet

Sponsor: Pfizer | Conditions: Acute Treatment of Migraine | Phase 3 | Status: RECRUITING